Resources Contact Us Home
Multi-user animation coupled to bulletin board

Image Number 6 for United States Patent #8018455.

A multi-user animation process receives input from multiple remote clients to manipulate avatars through a modeled 3-D environment. Each user is represented by an avatar. The 3-D environment and avatar position/location data is provided to client workstations, which display a simulated environment visible to all participants. A text or speech-based bulletin board application is coupled to the animation process. The bulletin board application receives text or speech input from the multiple remote users and publishes the input in a public forum. The bulletin board application maintains multiple forums organized by topic. Access or participation to particular forums is coordinated with the animation process, such that each user may be permitted access to a forum only when the user's avatar is located within a designated room or region of the modeled 3-D environment.

  Recently Added Patents
Polymer composites having highly dispersed carbon nanotubes
Diagnostic data interchange
Ascertaining presentation format based on device primary control determination
Imaging device, method and computer readable medium
Large carrying case
Eye therapy system
Method and apparatus for using virtual machine technology for managing parallel communicating applications
  Randomly Featured Patents
Method for programming and erasing an array of NMOS EEPROM cells that minimizes bit disturbances and voltage withstand requirements for the memory array and supporting circuits
Polyethylene composition
Container for concentrated powder or liquid substances to be put in solution within an enclosure at the time of use
Ablation catheter
Handle for a continuous flow drywall finishing tool
Tamper-proof container cap assembly and related methods
Distillation unit for solvent
Low-melting glass paste and cellulose nitrate therefor
Device for subcutaneous injection without a needle
Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates